Elliot Sussman - Universal Health Independent Director
| UHS Stock | USD 189.01 7.55 4.16% |
Director
Dr. Elliot J Sussman, M.D. is Director of the Company. in March 2018. He is Chairman of The Villages Health. He previously served as President and Chief Executive Officer of Lehigh Valley Hospital and Health Network from 1993 through 2010. He was a member of the Board of Directors of iCAD, Inc. since 2002 since 2018.
| Age | 68 |
| Tenure | 7 years |
| Address | Universal Corporate Center, King of Prussia, PA, United States, 19406-0958 |
| Phone | 610 768 3300 |
| Web | https://www.uhs.com |
Elliot Sussman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Elliot Sussman against Universal Health stock is an integral part of due diligence when investing in Universal Health. Elliot Sussman insider activity provides valuable insight into whether Universal Health is net buyers or sellers over its current business cycle. Note, Universal Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Universal Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Elliot Sussman over six months ago Disposition of 5000 shares by Elliot Sussman of Universal Health at 67.69 subject to Rule 16b-3 |
Universal Health Management Efficiency
The company has Return on Asset of 0.0682 % which means that on every $100 spent on assets, it made $0.0682 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1634 %, implying that it generated $0.1634 on every 100 dollars invested. Universal Health's management efficiency ratios could be used to measure how well Universal Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.1 in 2025, whereas Return On Tangible Assets are likely to drop 0.06 in 2025. At this time, Universal Health's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 13.5 B in 2025, whereas Return On Tangible Assets are likely to drop 0.06 in 2025.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Michael Dinkins | Community Health Systems | 67 | |
| Nancy Schlichting | Encompass Health Corp | 66 | |
| Meg Crofton | HCA Holdings | 67 | |
| Marilyn Tavenner | Select Medical Holdings | 69 | |
| Thomas Scully | Select Medical Holdings | 63 | |
| Tammy Romo | Tenet Healthcare | 58 | |
| James Bierman | Tenet Healthcare | 68 | |
| William Frist | Select Medical Holdings | 69 | |
| Donald Correll | Encompass Health Corp | 70 | |
| Phyllis Yale | DaVita HealthCare Partners | 62 | |
| Richard Fisher | Tenet Healthcare | 72 | |
| Barbara Desoer | DaVita HealthCare Partners | 67 | |
| Christopher Lynch | Tenet Healthcare | 63 | |
| Elizabeth Hirsch | Community Health Systems | 67 | |
| Paul Diaz | DaVita HealthCare Partners | 58 | |
| Cecil Haney | Tenet Healthcare | 65 | |
| Martha Marsh | AMN Healthcare Services | 72 | |
| Michael Johns | AMN Healthcare Services | 78 | |
| Lloyd Austin | Tenet Healthcare | 65 | |
| John Fry | Community Health Systems | 60 | |
| Ross Comeaux | Community Health Systems | N/A | |
Management Performance
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0682 |
Universal Health Services Leadership Team
Elected by the shareholders, the Universal Health's board of directors comprises two types of representatives: Universal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Universal. The board's role is to monitor Universal Health's management team and ensure that shareholders' interests are well served. Universal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Universal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lynda Smirz, Chief VP | ||
| Elliot Sussman, Independent Director | ||
| Matthew Peterson, Executive Vice President of the company and President of Behavioral Health Division | ||
| Lawrence Gibbs, Independent Director | ||
| Geraldine Geckle, Senior Resources | ||
| Warren Nimetz, Director | ||
| Victor Radina, Senior Development | ||
| Marvin Pember, Executive Vice President, President of Acute Care Division | ||
| Eileen McDonnell, Lead Independent Director | ||
| Alan Miller, Executive Chairman, CEO, Member of Executive Committee and Member of Fin. Committee | ||
| Michael Nelson, Senior Services | ||
| Maria Singer, Independent Director | ||
| Marc Miller, President, Director and Member of Fin. Committee | ||
| Matthew Klein, Senior Counsel | ||
| Jim Clark, Senior Division | ||
| Edward Sim, Executive Division | ||
| Thomas Day, Senior Division | ||
| Maria Zangardi, Senior Officer | ||
| Steve Filton, Chief Financial Officer, Executive Vice President, Secretary |
Universal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Universal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0682 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 16.97 B | ||||
| Shares Outstanding | 58.71 M | ||||
| Shares Owned By Insiders | 4.58 % | ||||
| Shares Owned By Institutions | 94.44 % | ||||
| Number Of Shares Shorted | 1.79 M | ||||
| Price To Earning | 13.68 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Universal Stock Analysis
When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.